Market Overview

McNicoll Lewis Vlak Downgrades Alnylam Pharmaceuticals, Inc. to Hold, Raises PT to $27.50

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for ALNY

DateFirmActionFromTo
Aug 2016JP MorganMaintainsOverweight
Aug 2016JefferiesMaintainsBuy
Aug 2016Morgan StanleyInitiates Coverage onOverweight

View More Analyst Ratings for ALNY
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (ALNY)